This two-day event is designed as a dedicated platform for stakeholders across the UK and European healthcare ecosystem to explore the evolving role of Real-World Evidence (RWE) in shaping market access, pricing, and reimbursement strategies.
With increasing pressure to deliver cost-effective, evidence-based care, this summit brings together thought leaders from across pharma, biotech, regulators, payers, HTA bodies, and digital health to address the region’s most pressing access and pricing challenges.
Generating regionally compliant, high-quality evidence
Outcomes-based, managed entry, and adaptive approaches
Addressing fragmentation in pricing and reimbursement across Europe
Preparing for JCA, NICE’s Evidence Standards Framework, and evolving payer needs
Leveraging EHRs, AI, and real-time registries for faster access
In-depth case studies on RWE applications in European and UK HTA submissions
Strategic discussions on region-specific pricing and reimbursement frameworks
Updates on EU HTA regulation, JCA implementation, and NICE RWE standards
Exploration of AI, digital endpoints, and patient-reported outcomes in evidence generation
Networking with European regulators, payers, and market access leaders
Aliki Taylor
Aliki Taylor
Reya Sharma
Reya Sharma
Shikta Das
Shikta Das
Andrew Ballantyne
Andrew Ballantyne
Ramota Alaran
Ramota Alaran
Rohit Mistry
Rohit Mistry
Dr Amrit Kaliasethi
Dr Amrit Kaliasethi
John Purdy
John Purdy
Rasmus Hjorth
Rasmus Hjorth
Dr Bai Li
Dr Bai Li
Omar Ali
Omar Ali
Mike McMillan
Mike McMillan
Mounia Chabane
Mounia Chabane
Millennium Hotel and Conference Centre Gloucester London
